Chemical Name: 4,4-Diethoxy-N,N-dimethyl-1-butanamine
CAS.NO: 1116-77-4
Synonyms:
4,4-Diethoxy-N,N-dimethylbutylamine
4,4-diethoxy-N,N-dimethylbutan-1-amine
4,4-Diethoxy-N,N-dimethylbutanamine
1-(N,N-Dimethylamino)-4,4-diethoxybutane
4-(Dimethylamino)butyraldehyde Diethyl Acetal
N,N-Dimethyl-4-aminobutanal diethyl acetal
4-Dimethylaminobutanal diethyl acetal
Molecular Formula: C10H23NO2
Molecular Weight: 189.29500
Physical and Chemical Properties:
Density:0.844g/cm3
Boiling point:230.7ºC at 760 mmHg
Melting point: /
Flash point:158 °F
Refractive index: 1.421
Specification:
Appearance:Colorless to light-yellowish lucent liquid
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Zolmitriptan CAS:139264-17-8
Intermediates of Sumatriptan succinate CAS:103628-48-4
Intermediates of Sumatriptan CAS:103628-46-2
We are professional 4,4-Diethoxy-N,N-dimethyl-1-butanamine manufacturer and 4-Dimethylaminobutanal diethyl acetal supplier in China, We offer quality 4,4-Diethoxy-N,N-dimethylbutanamine you can fully trust, also we have India factory and producer of 4,4-diethoxy-N,N-dimethylbutan-1-amine,Pls send inquiry of 4-(Dimethylamino)butyraldehyde Diethyl Acetal CAS:1116-77-4 to info@nbinno.com if you have any interests, thank you!
Related News: As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.3-Isocyanatopropyltriethoxysilane CAS:24801-88-5 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.2-Fluoro-4-methyl-5-nitropyridine Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.[(2S)-1-acetamido-3-chloropropan-2-yl] acetate CAS:183905-31-9 Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.
